Mark Rosenblum has joined the board of directors of Indianapolis-based medical device company NICO Corp. He has authored seven books and more than 250 articles and chapters relating to neurosurgery and neuroscience and has received many awards for his research and clinical work, including from the American Association of Neurological Surgeons and Congress of Neurological Surgeons for life-long contributions to neuro-oncology.

Rosenblum currently is chairman emeritus of the Department of Neurosurgery in the Henry Ford Health System, where he expanded the department over 22 years from four surgeons to 32 physicians and scientists. He also founded and served as a co-director of the nationally recognized Hermelin Brain Tumor Center and HFHS Neurosciences Institute. As a physician executive, Rosenblum has focused on team building and integration, as well as technology development and process innovation.

He obtained his B.S. at Rensselaer Polytechnic Institute (1965), M.D. at New York Medical College (1969), Medical Internship at the University of Michigan (1970), Staff Associate at the National Cancer Institute (NCI)(1972), Surgical Residency at the University of California, Los Angeles (1973) and Neurosurgery Residency at the University of California, San Francisco (UCSF) (1979). At UCSF he helped develop its world-leading Brain Tumor Research Center, became Professor of Neurosurgery, and was continuously funded by the NCI and American Cancer Society for early research on cancer stem cells. He founded and chaired the Section on Tumors of the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS), the largest specialty organization of neuro-oncology in his field.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}